Allosteric modulators targeting CNS muscarinic receptors
- PMID: 28935216
- DOI: 10.1016/j.neuropharm.2017.09.024
Allosteric modulators targeting CNS muscarinic receptors
Abstract
Muscarinic acetylcholine receptors are G protein-coupled receptors (GPCRs) which are broadly expressed in the central nervous system (CNS) and other tissues in the periphery. They emerge as important drug targets for a number of diseases including Alzheimer's disease, Parkinson's disease, and schizophrenia. Muscarinic receptors are divided into five subtypes (M1-M5) of which M1-M4 have been crystalized. All subtypes possess at least one allosteric binding site which is located in the extracellular region of the receptor on top of the ACh (i.e. orthosteric) binding site. The former can be specifically targeted by chemical compounds (mostly small molecules) and binding of such allosteric modulators affects the affinity and/or efficacy of orthosteric ligands. This allows highly specific modulation of GPCR function and, from a drug discovery point of view, may be advantageous in terms of subtype selectivity and biased signaling. There is a plethora of allosteric modulators for all five muscarinic receptor subtypes. This review presents the basic principles of allosteric modulation of GPCRs on both the molecular and structural level focusing on allosteric modulators of the muscarinic receptor family. Further we discuss dualsteric (i.e. bitopic orthosteric/allosteric) ligands emphasizing their potential in modulating muscarinic receptor dynamics and signaling. The common mechanisms of muscarinic receptor allosteric modulation have been proven to be generalizable and are at play at many, if not all GPCRs. Given this paradigmatic role of muscarinic receptors we suggest that also new developments in muscarinic allosteric modulation may also be extended to other members of the GPCR superfamily. This article is part of the Special Issue entitled 'Neuropharmacology on Muscarinic Receptors'.
Keywords: Allosteric modulation; Biased signaling; Bitopic ligands; Dualsteric ligands; Muscarinic acetylcholine receptors; Subtype-selectivity.
Copyright © 2017 Elsevier Ltd. All rights reserved.
Similar articles
-
Current Advances in Allosteric Modulation of Muscarinic Receptors.Biomolecules. 2020 Feb 18;10(2):325. doi: 10.3390/biom10020325. Biomolecules. 2020. PMID: 32085536 Free PMC article. Review.
-
Development of allosteric modulators of GPCRs for treatment of CNS disorders.Neurobiol Dis. 2014 Jan;61:55-71. doi: 10.1016/j.nbd.2013.09.013. Epub 2013 Sep 27. Neurobiol Dis. 2014. PMID: 24076101 Free PMC article. Review.
-
Muscarinic receptor subtype distribution in the central nervous system and relevance to aging and Alzheimer's disease.Neuropharmacology. 2018 Jul 1;136(Pt C):362-373. doi: 10.1016/j.neuropharm.2017.11.018. Epub 2017 Nov 11. Neuropharmacology. 2018. PMID: 29138080 Review.
-
Structural Characteristics of the Allosteric Binding Site Represent a Key to Subtype Selective Modulators of Muscarinic Acetylcholine Receptors.Mol Inform. 2015 Aug;34(8):526-30. doi: 10.1002/minf.201500025. Epub 2015 Jul 1. Mol Inform. 2015. PMID: 27490498
-
Dualsteric GPCR targeting and functional selectivity: the paradigmatic M(2) muscarinic acetylcholine receptor.Drug Discov Today Technol. 2013 Summer;10(2):e245-52. doi: 10.1016/j.ddtec.2012.12.003. Drug Discov Today Technol. 2013. PMID: 24050275 Review.
Cited by
-
Linkers in Bitopic Agonists Shape Bias Profile among Transducers for the Dopamine D2 and D3 Receptors.ACS Pharmacol Transl Sci. 2024 Jul 26;7(8):2333-2349. doi: 10.1021/acsptsci.4c00119. eCollection 2024 Aug 9. ACS Pharmacol Transl Sci. 2024. PMID: 39144557
-
Current Advances in Allosteric Modulation of Muscarinic Receptors.Biomolecules. 2020 Feb 18;10(2):325. doi: 10.3390/biom10020325. Biomolecules. 2020. PMID: 32085536 Free PMC article. Review.
-
Clemastine Promotes Differentiation of Oligodendrocyte Progenitor Cells Through the Activation of ERK1/2 via Muscarinic Receptors After Spinal Cord Injury.Front Pharmacol. 2022 Jul 5;13:914153. doi: 10.3389/fphar.2022.914153. eCollection 2022. Front Pharmacol. 2022. PMID: 35865954 Free PMC article.
-
Repositioning Dequalinium as Potent Muscarinic Allosteric Ligand by Combining Virtual Screening Campaigns and Experimental Binding Assays.Int J Mol Sci. 2020 Aug 19;21(17):5961. doi: 10.3390/ijms21175961. Int J Mol Sci. 2020. PMID: 32825082 Free PMC article.
-
Crystal structure of the M5 muscarinic acetylcholine receptor.Proc Natl Acad Sci U S A. 2019 Dec 17;116(51):26001-26007. doi: 10.1073/pnas.1914446116. Epub 2019 Nov 26. Proc Natl Acad Sci U S A. 2019. PMID: 31772027 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources